SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0221
SARS-CoV-2 (2019-nCoV)
ELISA, Neutralization
Human
IgG1, kappa
Iv0222
SARS-CoV-2(2019-nCoV), SARS-CoV
ELISA, Neutralization
Human
IgG1, kappa
S309
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization
Human
IgG1, kappa
m336
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
FCM, Neutralization, SPR
Human
IgG1
4V2
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
VIR-7229
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, lambda2
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2H97
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
S2E12
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, lambda2